Cyanine5.5 NHS酯 (Cyanine5.5 NHS ester)

貨號	數量	價格	交貨時間
17020	1 mg	$125	現貨
27020	5 mg	$260	現貨
47020	25 mg	$510	現貨
57020	50 mg	$895	現貨
67020	100 mg	$1490	現貨

批量詢價

Found better price? Let us know and we will propose the way forward!

Cyanine5.5 NHS 酯是一種活性染料，用於標記多肽、蛋白質和寡核苷酸中的氨基，是 Cy5.5® NHS 酯的類似物。

Cy5.5 是一種遠紅（和近紅外）發射染料，非常適合需要考慮背景螢光的螢光測量。它也適用於體內近紅外成像實驗。

該試劑可以替代 Cy5.5® NHS 酯和 DyLight 680 NHS 酯。

以
ChemDraw 格式下載

顧客還購買了這個產品

磺基-Cyanine7.5 羧酸

羧酸形式的水溶性近紅外熒光染料。由於四個磺基的存在，該染料具有高親水性。

BDP TR azide

BDP TR is a red-emitting fluorophore for the ROX channel. This is an azide for copper-catalyzed and copper-free сlick chemistry conjugation.

JOE phosphoramidite, 5-isomer

JOE phosphoramidite is a xanthene dye phosphoramidite used in oligo synthesis. Its absorption and emission spectra are located between the FAM and TAMRA channels.

外观:	深藍色至紫色固體
分子量:	767.66
CAS 编号:	2375105-86-3
分子式:	C₄₄H₄₆N₃BF₄O₄
IUPAC 名称:	1H-Benz[e]indolium, 2-[5-(1,3-dihydro-1,1,3-trimethyl-2H-benz[e]indol-2-ylidene)-1,3-pentadien-1-yl]-3-[6-[(2,5-dioxo-1-pyrrolidinyl)oxy]-6-oxohexyl]-1,1-dimethyl-
溶解度:
质量控制:	NMR ¹H, HPLC-MS (95%)
储存条件:	儲存：收到後-20℃避光保存12個月。運輸：室溫最多可保存3週。避免長時間暴露在光線下。乾燥。
MSDS:	下載
	產品規格

激发/吸收极大值，纳米:	684
ε, 摩尔吸光系数，cm⁻¹:	198000
发射极大值，纳米:	710
荧光量子产率:	0.2
CF₂₆₀:	0.07
CF₂₈₀:	0.03

產品引用

Liu, Q.; Wang, C.; Zhu, M.; Liu, J.; Duan, Q.; Midgley, A.C.; Liu, R.; Jiang, B.; Kong, D.; Chen, Q.; Zhuang, J.; Huang, X. Self‐Assembly of Heterogeneous Ferritin Nanocages for Tumor Uptake and Penetration. Advanced Science, 2024, 11(17), 2309271. doi: 10.1002/advs.202309271
Han, G.; Kim, H.; Jang, H.; Kim, E.S.; Kim, S.H.; Yang, Y. Oral TNF-α siRNA delivery via milk-derived exosomes for effective treatment of inflammatory bowel disease. Bioactive Materials, 2024, 34, 138-149. doi: 10.1016/j.bioactmat.2023.12.010
Wen, H.; Martínez, M.G.; Happonen, E.; Qian, J.; Vallejo, V.G.; Mendazona, H.J.; Jokivarsi, K.; Scaravilli, M.; Latonen, L.; Llop, J.; Lehto, V.-P.; Xu, W. A PEG-assisted membrane coating to prepare biomimetic mesoporous silicon for PET/CT imaging of triple-negative breast cancer. International journal of pharmaceutics, 2024, 652, 123764. doi: 10.1016/j.ijpharm.2023.123764
Kopp, A.; Kwon, H.; Johnston, C.; Vance, S.; Legg, J.; Galson-Holt, L.; Thurber, G.M. Impact of tissue penetration and albumin binding on design of T cell targeted bispecific agents. Neoplasia, 2024, 48, 100962. doi: 10.1016/j.neo.2023.100962